With the help of JPL, the NCI-supported Early Detection Research Network (EDRN) identified six new Food and Drug Administration-approved biomarkers needed to root out cancer. Those biomarkers have now been used in over a million patient diagnostic tests around the globe.
By applying NASA technology, EDRN will be able to compile their collective findings into a standardized, searchable data network for scientists around the globe, paving the way for early diagnosis of cancer or cancer risk.
In the renewed partnership, JPL will expand data science efforts to research and applying those technologies to NCI-sponsored programs including the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions, and the Informatics Technology for Cancer Research initiative.
"From a NASA standpoint, there are significant opportunities to develop new data science capabilities that can support both the mission of exploring space and cancer research using common methodological approaches," Dan Crichton, the head of JPL's Center for Data Science and Technology, who helped form the informatics center in support of EDRN initiatives, said in the statement.
"We have a great opportunity to perfect those techniques and grow JPL's data science technologies, while serving our nation."